MNOV
Medicinova Inc
$1.43
+0.01 (+0.70%)
At close · Jul 2
Market Cap
$70.39M
Shares
49,221,246
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.43
Open$1.48
Day$1.41–1.48
52W$1.17–1.96
Avg vol 30d59K
Short int102K · 0.2% float · 2.7d
Short vol52%
Last earningsFeb 20, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+1% above
+
Price vs 50-day avg
+6% above
◦
RSI (14)
62 · neutral
+
MACD trend
positive
◦
52-week position
33% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $1 › 200d $1 — 200d above 50d
−
Institutional flow
-9% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.21% of float · ▼ -40.7% MoM · 2.7 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
30 holders — mid 3-yr range
Fundamentals
Fair
+
Revenue growth
+52% Y/Y
−
EPS growth
−4% Y/Y
−
Free cash flow
$-9.8M
+
Balance sheet
net cash $30.8M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+1% above
Bullish
Price vs 50-day avg
+6% above
Bullish
RSI (14)
62 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
33% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-9% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.21% of float · ▼ -40.7% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
30 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 33%
52-wk high $2
vs 200-day avg +1%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MNOV
this stock
Medicinova Inc
|
$70.39M | +9.2% | — | — | 0.2% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MNOV | +9.2% | +8.3% | +0.7% | +8.3% | +9.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +7.7% | +9.6% | -7.3% | +8.6% | -0.1% |